MediciNova, Inc.

This stock has a reasonable momentum. MediciNova, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in MediciNova, Inc..
Log in to see more information.
MediciNova, Inc. is a biopharmaceutical company. It is engaged in acquiring and developing novel, sm...
MNOV Fundamental Data by TradingView

News

StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV)
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV)

Ticker Report Investment analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV - Get Free Report) in a research report issued on Thursday. The firm set a "hold" rating on the...\n more…

MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com
MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com

Zolmax Analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV - Get Free Report) in a research note issued to investors on Thursday. The brokerage set a "hold" rating on the...\n more…

MediciNova says abstract regarding MN-166 accepted for poster presentation
MediciNova says abstract regarding MN-166 accepted for poster presentation

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

Globe Newswire LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock...\n more…

MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com

Zolmax StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV - Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company's...\n more…

MediciNova (NASDAQ:MNOV) Stock Price Crosses Above 200-Day Moving Average of $1.36
MediciNova (NASDAQ:MNOV) Stock Price Crosses Above 200-Day Moving Average of $1.36

Zolmax Shares of MediciNova, Inc. (NASDAQ:MNOV - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.36 and traded as high as...\n more…